How to Import Generic Medicines from India: A Step-by-Step Guide for Buyers

India supplies a large share of the world’s affordable generic medicines. For importers, hospitals, NGOs and government buyers, sourcing directly from India can significantly reduce procurement costs while maintaining quality — provided you follow the right process. Here is a clear, step-by-step guide.

1. Define your product requirement

Start with a clear list of the molecules, strengths, dosage forms and pack sizes you need, along with estimated annual volumes. A well-defined requirement lets a supplier quote accurately and match you with the correct manufacturing partner.

2. Choose the right sourcing partner

Working with a merchant exporter gives you multi-manufacturer access from a single point of contact — the widest product range, competitive pricing and flexible quantities. Confirm the exporter sources only from WHO-GMP certified facilities and can provide complete regulatory documentation.

3. Verify quality and compliance

• Manufacturing standard: products should come from WHO-GMP, and where relevant EU-GMP or other stringent-regulator approved facilities.
• Documentation: Certificate of Pharmaceutical Product (COPP), Certificate of Analysis (COA), GMP certificate and Free Sale Certificate.
• Stability data suited to your climatic zone.

4. Handle product registration in your country

Most countries require medicines to be registered with the national regulatory authority before import. Your supplier should provide the dossier (typically in CTD format) and supporting documents. See our country-by-country market pages for the relevant authority and pathway.

5. Confirm pricing, Incoterms and lead times

Agree on pricing terms (FOB, CIF, etc.), minimum order quantities, production lead times and payment terms in writing before placing a purchase order.

6. Logistics, shipping and delivery

Temperature-sensitive products need validated cold-chain handling. A capable exporter arranges export documentation, packing, labeling to your market’s requirements and freight to your port.

Ready to start?

Tell us your market, products and volumes and our export team will prepare a tailored quotation with documentation included. Request a quote.

Selecting the Right Products for Your Market

Successful pharmaceutical importation begins with strategic product selection aligned to your market's therapeutic priorities and regulatory framework. When evaluating generic medicines from India, consider disease prevalence in your target region—cardiovascular medications, anti-diabetics, antibiotics, and antiretrovirals typically represent high-volume categories across emerging markets. Review your national essential medicines list and hospital formularies to identify gaps where Indian generics offer cost-effective alternatives to originator brands.

Formulation type matters significantly for market acceptance. Oral solid dosage forms (tablets, capsules) dominate most markets due to stability and ease of distribution, while injectables command premium pricing but require cold chain infrastructure. Explore our complete product catalogue to assess availability across multiple therapeutic areas including oncology, neurology, gastroenterology, and respiratory care. Prioritize molecules with established bioequivalence data and products manufactured at GMP-certified facilities that meet your country's specific regulatory standards—whether US FDA, EMA, MHRA, or local health authority requirements.

Packaging configurations should match your distribution model: hospital bulk packs differ from retail pharmacy strips. Request samples to evaluate packaging quality, labeling clarity, and shelf-life adequacy for your supply chain duration. Consider patient compliance factors such as dosage frequency and tablet size, particularly for geriatric and pediatric populations.

Understanding India's Pharmaceutical Supply Chain Structure

India's pharmaceutical export ecosystem operates through distinct channels, and understanding these structures helps importers identify the right partnership model. Direct manufacturer relationships offer price advantages but require significant order volumes, lengthy credit negotiations, and managing multiple vendor relationships for diverse product portfolios. Manufacturers typically focus on production efficiency rather than export documentation complexities or market-specific regulatory navigation.

Merchant exporters like Tuli Enterprise serve as specialized intermediaries with established networks across 95+ countries, providing critical advantages for international buyers. We maintain relationships with multiple GMP-certified manufacturing partners, enabling product diversification without minimum order quantity constraints per manufacturer. This model proves particularly valuable for importers building initial market presence or those requiring smaller volumes across multiple therapeutic categories.

Merchant exporters handle export documentation, regulatory compliance coordination, quality assurance protocols, and logistics management—functions that would otherwise require importers to maintain dedicated teams for each manufacturer relationship. Our PHARMEXCIL and FPME memberships ensure adherence to export quality standards and provide importers with additional verification of operational legitimacy. For buyers requiring specific formulations or strengths not available in standard portfolios, we facilitate contract manufacturing arrangements with qualified production facilities.

Regulatory Dossier Preparation and Documentation Standards

Comprehensive regulatory documentation separates professional pharmaceutical exporters from commodity traders. Before shipment, importers should receive complete dossier packages enabling smooth customs clearance and regulatory authority submissions in destination countries. A Certificate of Pharmaceutical Product (COPP) issued by Indian drug authorities confirms manufacturing license validity, GMP compliance, and marketing authorization status—this document holds particular importance for WHO Prequalification pathways and stringent regulatory authority submissions.

Certificate of Analysis (CoA) for each batch provides laboratory-verified confirmation that products meet pharmacopoeial specifications (IP, BP, USP, or EP standards). Request CoAs from accredited laboratories with ISO 17025 certification. Common Technical Document (CTD) format dossiers in Module 3 (quality) and abbreviated Module 2 (summaries) facilitate faster regulatory reviews in ICH-aligned countries. For markets requiring full registration dossiers, ensure your exporter provides stability study data demonstrating shelf-life claims under relevant climatic zones (Zone II, III, or IV as per ICH guidelines).

Free Sale Certificate (FSC) confirms products are freely marketable in India without restrictions, while manufacturing facility GMP certificates from national or international inspectorates (WHO-Geneva, USFDA, MHRA, TGA) provide independent quality system verification. Professional exporters maintain updated dossier libraries and understand country-specific requirements—whether ASEAN CTD format for Southeast Asian markets, ACTD for Gulf Cooperation Council countries, or specific requirements for African Union member states. Contact our documentation team at [email protected] to discuss your market's specific dossier requirements.

Incoterms, Payment Terms and Risk Management

International pharmaceutical trade involves significant financial exposure, making payment term negotiation and Incoterm selection critical risk management decisions. FOB (Free on Board) terms place responsibility for international freight and insurance on the buyer, offering lower initial pricing but requiring importers to manage shipping logistics and bear transit risk. CIF (Cost, Insurance, Freight) terms provide delivered pricing with exporter-arranged shipping, simplifying logistics for buyers but potentially limiting carrier selection and insurance coverage transparency.

For pharmaceutical shipments requiring temperature control or expedited delivery, CFR or CIP terms with clearly specified insurance coverage levels protect high-value consignments. First-time importers often prefer DDP (Delivered Duty Paid) arrangements where exporters handle destination customs clearance, though this requires exporters to maintain destination country tax registrations and assumes regulatory clearance risk.

Payment terms typically progress from 100% advance payment for initial orders to Letter of Credit arrangements (sight LC or usance LC with 30-90 day terms) as trading relationships mature. Irrevocable Letters of Credit through internationally recognized banks provide balanced risk protection—exporters receive payment assurance upon document presentation while importers ensure payment releases only against compliant documentation. For established buyers with strong credit profiles, open account terms with 30-60 day payment cycles become negotiable, though pharmaceutical products' regulatory sensitivity makes LC arrangements standard practice across most destination markets.

Consider trade credit insurance through export credit agencies or private insurers to protect against buyer default, political risk, or currency transfer restrictions in emerging markets. Bank guarantees or standby letters of credit provide additional security layers for large-volume contracts or government tender supplies.

Cold Chain and Specialized Pharmaceutical Logistics

Temperature-sensitive pharmaceutical products—including certain antibiotics, biologics, vaccines, and insulin formulations—demand unbroken cold chain integrity from manufacturing facility to end-user delivery. Even products with standard storage requirements (15-25°C) face risk during international transit through varied climatic zones, requiring validated packaging solutions and temperature monitoring systems.

Qualified exporters utilize thermal packaging with phase-change materials, insulated containers, and temperature data loggers recording continuous temperature profiles throughout shipment duration. Request pre-shipment validation studies demonstrating packaging performance under expected transit conditions and durations. Air freight remains the preferred mode for temperature-sensitive products despite higher costs, as ocean freight's 20-40 day transit times increase temperature excursion risks and require more sophisticated packaging solutions.

Reefer containers with active temperature control suit large-volume ocean shipments of cold chain products, though container availability and port infrastructure capabilities vary significantly across destination countries. Ensure your logistics provider offers temperature-controlled warehousing at origin and destination airports, with backup power systems preventing temperature excursions during ground handling delays.

Documentation should include temperature mapping studies, packaging qualification reports, and handling instructions in multiple languages. For markets with tropical climates (Zone IV), discuss accelerated stability data confirming product integrity under high temperature and humidity conditions. Our logistics partners maintain GDP (Good Distribution Practice) certifications and provide real-time shipment tracking with temperature monitoring alerts.

After-Shipment Support and Ongoing Partnership

Professional pharmaceutical exporters provide support extending well beyond cargo delivery. Batch documentation retention enables traceability for pharmacovigilance reporting—should adverse events occur, rapid access to manufacturing records, quality control data, and distribution chain documentation proves essential for regulatory investigations. Maintain organized archives of batch numbers, manufacturing dates, and distribution records for minimum seven-year periods as required by most regulatory frameworks.

Pharmacovigilance cooperation agreements clarify responsibilities for adverse event reporting between exporter, importer, and manufacturer. While local marketing authorization holders typically bear primary pharmacovigilance responsibility, exporters should facilitate communication channels to manufacturing facilities for technical inquiries and safety signal investigations. Request Standard Operating Procedures for complaint handling, product recall procedures, and quality deviation investigations.

Market surveillance support includes providing updated regulatory status information, manufacturing site change notifications, and formulation modifications that might trigger re-registration requirements in your market. Establish clear communication protocols for supply continuity—alternative sourcing arrangements if primary manufacturers face production interruptions, regulatory issues, or capacity constraints. Long-term partnerships benefit from periodic market visits, technical training for your quality assurance teams, and collaborative forecasting to ensure inventory availability during demand fluctuations.

Request Your Customized Import Quotation

Ready to establish a reliable supply chain for quality generic medicines from India? Tuli Enterprise brings two decades of merchant export expertise, serving importers, distributors, hospital chains, and government procurement agencies across 95+ countries. Our comprehensive service model covers product sourcing from GMP-certified manufacturers, complete regulatory documentation preparation, competitive pricing with flexible payment terms, and logistics coordination with temperature-controlled shipping options.

Contact our export team via WhatsApp at +91-9654-308-142 or email [email protected] with your specific product requirements, target quantities, destination country, and regulatory documentation needs. We'll provide detailed quotations including product specifications, pricing across multiple Incoterms, estimated delivery timelines, and documentation packages tailored to your market's regulatory framework. Visit our online catalogue to explore our extensive product range, or discuss contract manufacturing options for specialized formulations. Let's build a pharmaceutical supply partnership that delivers quality, compliance, and reliability to your market.